Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H.
暂无分享,去创建一个
Ying Wang | Lu Zhuang | Yuebo Zhang | Jiaxiang Chen | D. Mukhopadhyay | E. Radisky | B. Ji | Yuebo Zhang | S. Pandol | Cheng-lin Hu | A. Lugea | Jiaxiang Chen | J. Wan | Baoan Ji | Debabrata Mukhopadhyay | Stephen J Pandol | Xianbao Zhan | Yinghua Li | Yinghua Li | Aurelia Lugea | Evette S Radisky | Xiaohui Zhu | Xiao-hui Zhu | Yan Bi | Xianbao Zhan | Jianhua Wan | Fu Gui | Jia Guo | Ashley N Haddock | Yao Yao | Ji Shi | Brandy H Edenfield | Cheng Hu | Lizhi Zhang | Y. Bi | Ying Wang | Ashley N. Haddock | B. Edenfield | Yao Yao | Fu Gui | L. Zhuang | Jia Guo | Ji Shi | Lizhi Zhang | Zhuang Lu | Yan Bi
[1] M. Sahin-Tóth,et al. Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway , 2017, Digestive Diseases and Sciences.
[2] B. Ji,et al. Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis , 2011, Gut.
[3] D. Whitcomb. Hereditary pancreatitis: new insights into acute and chronic pancreatitis , 1999, Gut.
[4] J. Haynes,et al. Hereditary pancreatitis. , 1982, American family physician.
[5] S. Leach,et al. Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high doses of cholecystokinin. , 1991, The Journal of clinical investigation.
[6] Fan Wang,et al. Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis. , 2016, American journal of physiology. Gastrointestinal and liver physiology.
[7] C. Esmon. Targeting factor Xa and thrombin: impact on coagulation and beyond , 2013, Thrombosis and Haemostasis.
[8] A. Schömig,et al. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. , 2010, Atherosclerosis.
[9] M. Lerch,et al. Why does pancreatic overstimulation cause pancreatitis? , 2007, Annual review of physiology.
[10] U. Sack,et al. Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen , 2006, BMC gastroenterology.
[11] P. Banks,et al. Acute pancreatitis: bench to the bedside. , 2007, Gastroenterology.
[12] A. Szabó,et al. Increased Activation of Hereditary Pancreatitis-associated Human Cationic Trypsinogen Mutants in Presence of Chymotrypsin C* , 2012, The Journal of Biological Chemistry.
[13] Björn Schumacher,et al. The p53 network: cellular and systemic DNA damage responses in aging and cancer. , 2012, Trends in genetics : TIG.
[14] K. Zimmer,et al. Hereditary pancreatitis and mutation of the trypsinogen gene , 1999, Archives of disease in childhood.
[15] S. Tashiro,et al. The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis. , 2004, The journal of medical investigation : JMI.
[16] Huamin Wang,et al. Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice. , 2013, Gastroenterology.
[17] D. Mikhailidis,et al. Coagulation, Platelets, and Acute Pancreatitis , 2007, Pancreas.
[18] S. Korsmeyer,et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.
[19] M. Sahin-Tóth,et al. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[20] J. Meldolesi,et al. Pancreatic effects of ethionine: blockade of exocytosis and appearance of crinophagy and autophagy precede cellular necrosis. , 1982, The American journal of physiology.
[21] V. Pettilä,et al. Activated protein C retards recovery from coagulopathy in severe acute pancreatitis , 2016, Scandinavian journal of clinical and laboratory investigation.
[22] S. Lowe,et al. Control of apoptosis by p53 , 2003, Oncogene.
[23] D. Corey,et al. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin , 1992 .
[24] M. Steer,et al. Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[25] Walter G. Park,et al. Pharmacologic therapy for acute pancreatitis. , 2014, World journal of gastroenterology.
[26] B. Ji,et al. Intracellular Trypsin Induces Pancreatic Acinar Cell Death but Not NF-κB Activation* , 2009, The Journal of Biological Chemistry.
[27] B. Ji,et al. Robust acinar cell transgene expression of CreErT via BAC recombineering , 2008, Genesis.
[28] Wei Huang,et al. Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death , 2014, Cell Death and Disease.
[29] D. Morgan,et al. The Burden of Gastrointestinal and Liver Diseases, 2006 , 2006, The American Journal of Gastroenterology.
[30] R. Carter,et al. Acute pancreatitis , 1988, BMJ : British Medical Journal.
[31] Dhiraj Yadav,et al. The epidemiology of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.
[32] E. Conway,et al. Cross Talk Pathways Between Coagulation and Inflammation. , 2016, Circulation research.
[33] T. Fukui,et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis , 2004, European journal of gastroenterology & hepatology.
[34] P. Libby,et al. Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials , 2016, Thrombosis and Haemostasis.
[35] G. Cao,et al. Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis , 2012, European journal of gastroenterology & hepatology.
[36] Nancy A. Jenkins,et al. Simple and highly efficient BAC recombineering using galK selection , 2005, Nucleic acids research.
[37] L. Ferrell,et al. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. , 1986, The Journal of clinical investigation.
[38] H. Spronk,et al. Coagulation and non‐coagulation effects of thrombin , 2016, Journal of thrombosis and haemostasis : JTH.
[39] M. Steer,et al. Effects of ethionine on digestive enzyme synthesis and discharge by mouse pancreas. , 1980, The American journal of physiology.
[40] T. Wartmann,et al. Autoactivation of Mouse Trypsinogens Is Regulated by Chymotrypsin C via Cleavage of the Autolysis Loop* , 2013, The Journal of Biological Chemistry.
[41] S. Chari,et al. Protease inhibitors in acute pancreatitis: lessons from the bench and failed clinical trials. , 2005, Gastroenterology.
[42] Seth D. Crockett,et al. Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.
[43] G. Adler,et al. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. , 1991, Scandinavian journal of gastroenterology.
[44] J. Weissman,et al. Ero1p: a novel and ubiquitous protein with an essential role in oxidative protein folding in the endoplasmic reticulum. , 1998, Molecular cell.
[45] Clifford Goodman,et al. The burden of selected digestive diseases in the United States. , 2002, Gastroenterology.
[46] S. Coughlin,et al. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] F. Weiss. Pancreatic cancer risk in hereditary pancreatitis , 2014, Front. Physiol..
[48] C. Esmon. The interactions between inflammation and coagulation , 2005, British journal of haematology.
[49] M. Gorry,et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.
[50] R. Pai,et al. The Histopathology of PRSS1 Hereditary Pancreatitis , 2014, The American journal of surgical pathology.
[51] L. Gráf,et al. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis? , 1999, Biochemical and biophysical research communications.
[52] N. Bulleid,et al. The role of glutathione in disulphide bond formation and endoplasmic‐reticulum‐generated oxidative stress , 2006, EMBO reports.
[53] D. Whitcomb. Genetic risk factors for pancreatic disorders. , 2013, Gastroenterology.
[54] B. Göke,et al. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models. , 1989, Gastroenterology.
[55] G. Adler,et al. Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in caerulein-pancreatitis , 2006, Histochemistry.
[56] M. Lerch,et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. , 2001, JAMA.
[57] A. Saluja,et al. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[58] M. Sahin-Tóth,et al. A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation , 2018, Nature Communications.
[59] M. Tóth,et al. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. , 2000, Biochemical and biophysical research communications.
[60] W. Bechstein,et al. [Acute pancreatitis]. , 2004, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[61] A. Pandya,et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. , 1996, Genomics.
[62] C. Férec,et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. , 1996, Human molecular genetics.